Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.
Multiple locations, including Glendale
This study is recruiting in Germany. It is testing a digital intervention for depression.
In GermanyThis study is recruiting in the United States, in France, in Belgium, .... It is testing KarXT for Schizophrenia.
Multiple locations, including ChandlerThis study is recruiting in the United States. It is testing KYN-5356 for schizophrenia.
Multiple locations, including Little RockThis study is recruiting in the United States, in Australia, in Canada, .... It is testing Safety and Efficacy of KarXT + KarX-EC for Schizophrenia.
Multiple locations, including GilbertThis study is recruiting in the United States. It focuses on Schizophrenia.
Multiple locations, including Little RockThis study is recruiting in the United States. It is testing DT-101 for depression.
Multiple locations, including DeSotoThis study is recruiting in the United States, in the United Kingdom, in Bulgaria, .... It is testing DT-101 for depression.
Multiple locations, including BentonvilleThis study is recruiting in the United States. It focuses on adults with tardive dyskinesia who remain symptomatic while receiving or after stopping a VMAT2 inhibitor.
Multiple locations, including BryantThis study is recruiting in the United States. It focuses on ADHD.
In Las VegasThis study is recruiting in the United States, in France, in Argentina, .... It is testing KarXT for manic episodes in bipolarity type I, including participants taking lithium, valproate, or lamotrigine.
Multiple locations, including BentonvilleThis study is recruiting in the United States, in Brazil, in Hungary, .... It is testing esketamine for depression.
Multiple locations, including Birmingham